Valhalla Vitality review

Valhalla Vitality’s public weight-care menu is enough to establish that a prescribing service exists, but not enough to price a specific GLP-1 prescription. Its injectable and oral GLP-1 pages ask patients to sign in for pricing, dosing and full details, without publicly identifying the molecule. Do not assume either page means semaglutide or tirzepatide. The service also lists metformin and Metformin Synergy by name, again with essential details reserved for account holders. That named metformin offer is the clearer connection to the longevity prescription comparison; the generic GLP-1 category alone cannot establish a drug-specific cost. Ask for a written proposal before comparing the service with another provider’s fully described prescription.

The account requirement changes the amount of information available before you decide to proceed. A prospective patient cannot use the ordinary product pages to compare recurring medication cost, supply duration, formulation or dose-related changes. Creating an account is also not the same as a clinical evaluation, and paying for access or a consultation does not guarantee a particular prescription. If you choose to inquire, ask which medicine the clinician would consider, what services the proposed fee includes and whether any later pharmacy charge is separate. Use the tirzepatide lineup only after Valhalla has actually identified tirzepatide as the proposed product. A broad weight-loss category is not a reliable shortcut for that identification.

The service describes eligibility review by licensed U.S. providers and a clinical network, without naming the treating group or individual clinician on the public pages reviewed. It advertises nationwide service across all 50 states and describes pharmacy fulfillment after approval. These are useful outlines of the process, but the details of a continuing clinical relationship are still missing. Ask who will prescribe, whether the first evaluation is live or written, how follow-up is scheduled and how to contact a clinician with concerns. At-home laboratory testing is marketed separately, without a public requirement or payment arrangement tied to each GLP-1 or metformin offer. A testing catalog does not by itself establish that your prescription plan includes the tests the clinician might request.

The refund policy is more specific than the product information. Current terms say you can stop a particular order through your account until a provider approves it. After approval, the order cannot be canceled or refunded merely because you decide not to use the medication, cancel the program or change treatment duration. The policy does preserve exceptions such as pharmacy error, inability to fulfill, provider rejection and refunds required by law. This cutoff arrives before dispensing, so an unshipped order is not automatically refundable. Subscription cancellation must be completed in the account by 11:59 p.m. Eastern the day before renewal to prevent that cycle. A support message is not guaranteed to be processed in time. Those rules make it important to separate a cancellation request from confirmation that the account action actually took effect.

Valhalla does not name its dispensing pharmacy in the public legal and product material reviewed. It refers instead to a verified pharmacy and clinical network. Ask for the actual pharmacy, location and preparation when a prescription is proposed, including whether metformin is being supplied as a conventional generic or another formulation. The name Metformin Synergy does not disclose its complete ingredients on the public page. The compounded medication sourcing guide offers questions for that conversation if the GLP-1 proposal is compounded. Valhalla’s wide wellness catalog is not a substitute for those product-specific answers. The service may be worth discussing if you accept the account-based process, but its public information leaves too much unresolved for a purchase based simply on a category name or a promise of personalized care.